Q3 2025 Earnings Call Transcript November 4, 2025 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Q3 2025 Earnings Call Transcript November 4, 2025 Kura Oncology, Inc. misses on earnings expectations. Reported EPS is ...

The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.

Get the latest on Global Payments’ Q3 2025 results, Genius platform growth, Worldpay deal progress, and 2026 outlook.

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

Power demand worldwide will jump 30% in the next decade, as the push for electrification, buildout of data centers, and the ...

Operator: Good day, and welcome to the Cushman & Wakefield Third Quarter 2025 Earnings Call. [Operator Instructions] please note that this conference is being recorded.

Localized supply chains are crucial for mitigating geopolitical risks and ensuring operational continuity in the biopharmaceutical sector. Regulatory harmonization enhances access to medicines, ...

A momentous week in the technology sector made it clear there is no sign the boom in building AI infrastructure is slowing.

Operator: Good morning, and good evening. Thank you all for joining the conference call for the SK Telecom earnings results.

A landmark new report by DC Market Insights reveals a period of historic growth for the Global Data Center Market, the fundamental infrastructure powering the digital world. The market, valued at USD ...